Literature DB >> 20608165

[Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells].

D Baskaran, P V Spirin, V S Prasolov.   

Abstract

Leukemia is a heterogeneous group of malignant blood diseases, it could be characterized by the expansion of immature blast cells. It's still stay unknown the point molecular mechanism of leukemogenesis. It has been previously found that leukemia patients frequently have the mutations in genes responsible for normal proliferation and differentiation of hematopoietic stem cells. At present, scientific groups worldwide engaged in biomedical studies of structural and functional aspects of leukemic oncogenes and their role in human and beast leukemogenesis. In this review we describe the most recent conceptions of molecular properties of oncogenes activation of which may lead to the development of CBF-AML, in case of mutation in core-binding factors AML1 (CBFalpha) or CBFbeta.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20608165

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  3 in total

1.  Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells.

Authors:  Jing Zhang; Cang Liu; Ruiguang Hou
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

2.  RNA interference and deep sequencing as tools for identifying new genes involved in leukemogenesis.

Authors:  T D Lebedev; P V Spirin; N N Orlova; A V Kudryavtseva; N V Melnikova; A S Speranskaya; V S Prasolov
Journal:  Dokl Biochem Biophys       Date:  2013-03-13       Impact factor: 0.788

3.  Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors.

Authors:  Pavel Spirin; Timofey Lebedev; Natalia Orlova; Alexey Morozov; Nadezhda Poymenova; Sergey E Dmitriev; Anton Buzdin; Carol Stocking; Olga Kovalchuk; Vladimir Prassolov
Journal:  Oncotarget       Date:  2017-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.